In conclusion, for cN0/N1 NSCLC patients who received nICT, systemic mediastinal lymph node dissection was not associated with survival benefits but disrupted the repertoire of stem-like tumor-cytotoxic CD8+ T cells. The gene discussed is CD8A; the disease is non-small cell lung carcinoma.